Here are relevant reports on : portable-ultrasound-market
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021
The blood flow measurement devices market is projected to grow at a CAGR of 9.2%. The growth of the overall blood flow measurement devices market can be contributed to the growing prevalence of cardiovascular diseases and diabetes coupled with rising geriatric population, technological advancements, and the influx of VC funding.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Vascular Imaging Market by Technology (MRI, Ultrasound, CT, Hybrid, OCT), Application (Atherosclerosis, DVT, Vasculitis, Aneurysmal Disorders, AV Malformations, Tumours, Others), End User (Hospitals, Diagnostic Imaging Centers) - Global Forecast to 2030
The global vascular imaging market, valued at US$3.03 billion in 2024, stood at US$3.19 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$4.54 billion by the end of the period. The growth of the vascular imaging market is driven by the rising prevalence of cardiovascular diseases, including atherosclerosis, peripheral artery disease, and stroke, which demand early diagnosis and monitoring.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Ultrasound Needle Guides Market by Type (Reusable, Disposable), Application (Tissue Biopsy, Fluid Aspiration, Nerve Block, Regional Anesthesia, Vascular Access), End User (Hospitals, Clinics, ASC, Diagnostic Imaging Centers) & Region - Global Forecasts to 2027
The global ultrasound needle guides market, stood at US$274 million in 2022 and is projected to advance at a resilient CAGR of 6.1% from 2022 to 2028, culminating in a forecasted valuation of US$369 billion by the end of the period. Ultrasound needle guides have applications in the diagnosis and treatment of diseases such as cancer and CVD. The prevalence of these target diseases is increasing across the globe due to factors such as the rising geriatric population and the increasing adoption of sedentary lifestyles.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Europe Contrast Media Market by Product (Microbubble, Iodine, Gadolinium, Barium-based), Modality (CT, MRI, Ultrasound), Indication (Cancer, GIT, CVD, Musculoskeletal, Neurology, Urology), Route of Administration (IV, Oral), End User - Forecast to 2031
The Europe contrast media market is projected to reach USD 3.19 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Diagnostic Catheter Market by Type (Angiography, OCT, Ultrasound, Electrophysiology, Pressure and Hemodynamic Monitoring), Application Area (Cardiology, Urology, Neurology, Gastroenterology), End User (Hospitals, Imaging Centers) - Global Forecast to 2021
The global diagnostic catheters market is projected to grow at a CAGR of around 7.3%. The diagnostic catheters market comprises a network of players involved in the research and product development; raw material supply; medical device manufacturing; distribution and sale; and post-sales services. The major players in the global market are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc. (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (The Netherlands), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), C. R. Bard, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Ultrasound Probe Covers Market by Type (Disposable, Reusable), Material (Latex, Latex-free), Application (Endocavitary), End User (Hospitals, Diagnostic Imaging Centers, Maternity Centers, Ambulatory Surgical Centers) & Region - Global Forecast to 2027
The global ultrasound probe covers market in terms of revenue was estimated to be worth $213 million in 2022 and is poised to reach $283 million in 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
US Medical Simulation Market by offering (Anatomical Models [Patient {High Fidelity}, Surgical {Laparoscopic, Ortho, Gynec, Spine}, Trainers, Ultrasound], Software), Technology (3D Printing, Virtual Patient, Procedural Rehearsal), End User - Forecast 2030
The US Medical Simulation market, valued at USD 1.20 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2030, culminating in a forecasted valuation of USD 2.83 billion by the end of the period. The US medical simulation market continues to expand, supported by rising demand for advanced clinical training, stricter regulatory and accreditation requirements, and a growing healthcare workforce.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
